Orgenesis
$1.22
21
-$0.28-18.67% Hari ini
Statistik
Harga Tertinggi Hari
1.55
Harga Terendah Hari
1.12
52M Tertinggi
10.8
52M Terendah
1.12
Volum
90,333
Volum Purata
37,155
Kapasiti Pasaran
31.44M
Nisbah P/E
-
Pendapatan Dividen
-
Dividen
-
Akan Datang
Pendapatan
8NovDijangka
EPS yang dijangka
0.17
EPS sebenar
N/A
Orang Lain Juga Mengikuti
Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti ORGS. Ini bukan cadangan pelaburan.
Peserta
Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.
CRISPR Therapeutics
CRSP
Kapasiti Pasaran4.06B
Bluebird bio
BLUE
Kapasiti Pasaran108.22M
Sangamo Therapeutics
SGMO
Kapasiti Pasaran176.57M
Intellia Therapeutics
NTLA
Kapasiti Pasaran2.28B
Editas Medicine
EDIT
Kapasiti Pasaran308.46M
Pfizer
PFE
Kapasiti Pasaran164.39B
Biomarin Pharmaceutical
BMRN
Kapasiti Pasaran17.36B
Gilead Sciences
GILD
Kapasiti Pasaran98.35B
Adverum Biotechnologies
ADVM
Kapasiti Pasaran144.36M
Mengenai
Health Technology
Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Show more...
CEO
Vered Caplan
Pekerja
146
Negara
US
ISIN
US68619K2042